Pharmaceutical Bid defenses have traditionally been considered the gold standard for culminating the contract research organization (CRO) selection process, writes Laurie Halloran, president and chief executive of Halloran Consulting Group, in an Expert View piece giving her perspective on how both parties can make the most out of this process. 21 September 2017